Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertension

Journal of Hypertension

Volumn 33, Issue 4, 2015, Pages 836-842

  Rhee, Eugene P ^a,b   Clish, Clary B ^b   Pierce, Kerry A ^b   Saad, Ahmed ^c   Lerman, Lilach O ^c   Textor, Stephen C ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Hypertension; Metabolism; Metabolomics; Renal artery stenosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DEOXYHEMOGLOBIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IOTALAMIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY OCCLUSION; BLOOD SAMPLING; CALORIC INTAKE; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOPPLER FLOWMETRY; ESSENTIAL HYPERTENSION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY PARENCHYMA; KIDNEY PERFUSION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PEAK SYSTOLIC VELOCITY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PULSE PRESSURE; SODIUM INTAKE; SYSTOLIC BLOOD PRESSURE; AGED; ATHEROSCLEROSIS; BLOOD; COMPARATIVE STUDY; COMPLICATION; HYPERTENSION; KIDNEY; KIDNEY CIRCULATION; KIDNEY VEIN; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; CHROMATOGRAPHY, LIQUID; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MASS SPECTROMETRY; METABOLOMICS; MIDDLE AGED; RENAL ARTERY OBSTRUCTION; RENAL CIRCULATION; RENAL VEINS;

EID: 84938960249     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000470     Document Type: Conference Paper

References (34)

1. Rhee EP, Clish CB, Ghorbani A, Larson MG, Elmariah S, McCabe E, et al. A combined epidemiologic and metabolomic approach improves CKD prediction. J Am Soc Nephrol 2013; 24:1330-1338.
2. Owen EE, Robinson RR. Amino acid extraction and ammonia metabolism by the human kidney during the prolonged administration of ammonium chloride. J Clin Invest 1963; 42:263-276.
3. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 1980; 65:1162-1173.
4. Garibotto G, Valli A, Anderstam B, Eriksson M, Suliman ME, Balbi M, et al. The kidney is the major site of S-adenosylhomocysteine disposal in humans. Kidney Int 2009; 76:293-296.
5. Gloviczki ML, Glockner JF, Crane JA, McKusick MA, Misra S, Grande JP, et al. Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 2011; 58:1066-1072.
6. Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, et al. Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010; 55:961-966.
7. Eirin A, Gloviczki ML, Tang H, Gossl M, Jordan KL, Woollard JR, et al. Inflammatory and injury signals released from the poststenotic human kidney. Eur Heart J 2013; 34:540-548.
8. Gloviczki ML, Glockner J, Gomez SI, Romero JC, Lerman LO, McKusick M, et al. Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease. Invest Radiol 2009; 44:566-571.
9. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17:448-453.
10. Rhee EP, Ho JE, Chen MH, Shen D, Cheng S, Larson MG, et al. A genome-wide association study of the human metabolome in a community-based cohort. Cell Metab 2013; 18:130-143.
11. Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 2011; 121:1402-1411.
12. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res 2012; 40:W127-W133.
13. Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 2009; 37:W652-W660.
14. Rhee EP, Souza A, Farrell L, Pollak MR, Lewis GD, Steele DJ, et al. Metabolite profiling identifies markers of uremia. J Am Soc Nephrol 2010; 21:1041-1051.
15. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001; 344:431-442.
16. Keddis MT, Garovic VD, Bailey KR, Wood CM, Raissian Y, Grande JP. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant 2010; 25:3615-3622.
17. Textor SC, Wilcox CS. Renal artery stenosis: a common, treatable cause of renal failure? Annu Rev Med 2001; 52:421-442.
18. Carey RM. Are kidneys not ischemic in human renal vascular disease? Hypertension 2010; 55:838-839.
19. Nielsen K, Rehling M, Henriksen JH. Renal vein oxygen saturation in renal artery stenosis. Clin Physiol 1992; 12:179-184.
20. Wheatley K, Ives N, Gray R, Kalra PA, Moss JG, Baigent C, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009; 361:1953-1962.
21. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med 2014; 370:13-22.
22. Duranton F, Cohen G, De Smet R, Rodriguez M, Jankowski J, Vanholder R, et al. Normal and pathologic concentrations of uremic toxins. J Am Soc Nephrol 2012; 23:1258-1270.
23. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dammrich J, et al. Early interstitial changes in hypertension-induced renal injury. Hypertension 1993; 22:754-765.
24. Tullis MJ, Zierler RE, Caps MT, Bergelin RO, Cantwell-Gab K, Strandness DE Jr. Clinical evidence of contralateral renal parenchymal injury in patients with unilateral atherosclerotic renal artery stenosis. Ann Vasc Surg 1998; 12:122-127.
25. Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M, et al. Metabolomic profiling of uremic solutes in CKD patients. Hypertens Res 2010; 33:944-952.
26. Sato E, Kohno M, Yamamoto M, Fujisawa T, Fujiwara K, Tanaka N. Metabolomic analysis of human plasma from haemodialysis patients. Eur J Clin Invest 2011; 41:241-255.
27. Goek ON, Doring A, Gieger C, Heier M, Koenig W, Prehn C, et al. Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 2012; 60:197-206.
28. Shah VO, Townsend RR, Feldman HI, Pappan KL, Kensicki E, Vander Jagt DL. Plasma metabolomic profiles in different stages of CKD. Clin J Am Soc Nephrol 2013; 8:363-370.
29. Duranton F, Lundin U, Gayrard N, Mischak H, Aparicio M, Mourad G, et al. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function. Clin J Am Soc Nephrol 2014; 9:37-45.
30. Sharma K, Karl B, Mathew AV, Gangoiti JA, Wassel CL, Saito R, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol 2013; 24:1901-1912.
31. Goek ON, Prehn C, Sekula P, Romisch-Margl W, Doring A, Gieger C, et al. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol Dial Transplant 2013; 28:2131-2138.
32. Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int 2014; 85:1214-1224.
33. Kalim S, Clish CB, Wenger J, Elmariah S, Yeh RW, Deferio JJ, et al. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J Am Heart Assoc 2013; 2:e000542.
34. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 2011; 7:e1002215.